Literature DB >> 12127315

Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.

H Dichtelmüller1, D Rudnick, M Kloft.   

Abstract

Inactivation of lipid enveloped viruses by treatment with octanoic acid has been investigated for three intravenous immunoglobulin preparations, using Human Immunodeficiency Virus, Bovine Viral Diarrhoea Virus, Sindbis Virus and Pseudorabies Virus as test viruses. At a concentration of 7.45 g octanoic acid per kg solution complete inactivation of lipid enveloped viruses to below detectable level (>5.36, >4.68, >6.25 and >5.55 log(10), respectively) was achieved within the first minutes of treatment. Octanoic acid treatment as described here, has been demonstrated as an effective and rapid virus inactivation procedure, which shows high robustness at the tested ranges of temperature, pH and protein content of the test material. However, pH must be considered as a critical parameter of treatment, as octanoic acid fails to inactivate lipid coated viruses at basic pH. At suitable conditions, e.g. pH<6.0 and a concentration of >3.7 g/kg, octanoic acid treatment gives reliable and highly effective inactivation of lipid enveloped viruses. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127315     DOI: 10.1006/biol.2002.0332

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  9 in total

1.  Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells.

Authors:  Kevin A Harvey; Candace L Walker; Zhidong Xu; Phillip Whitley; Thomas M Pavlina; Mary Hise; Gary P Zaloga; Rafat A Siddiqui
Journal:  J Lipid Res       Date:  2010-09-17       Impact factor: 5.922

2.  Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.

Authors:  Magdy El-Ekiaby; Mariángela Vargas; Makram Sayed; George Gorgy; Hadi Goubran; Mirjana Radosevic; Thierry Burnouf
Journal:  PLoS Negl Trop Dis       Date:  2015-02-26

Review 3.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

Review 4.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

Review 5.  Ebola virus convalescent blood products: where we are now and where we may need to go.

Authors:  Thierry Burnouf; Jerard Seghatchian
Journal:  Transfus Apher Sci       Date:  2014-10       Impact factor: 1.764

6.  Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.

Authors:  Josephine H Cheng; Yu-Wen Wu; Chen-Yun Wang; Sharon S Wu; Cheum L Hong; Karen W Chan; Leo X Liao; Xisheng Cao; Bin Wang; Thierry Burnouf
Journal:  Blood Transfus       Date:  2021-08-04       Impact factor: 3.443

7.  Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.

Authors:  Ying-Jan Weng; Anne Husebekk; Björn Skogen; Mette Kjaer; Liang-Tzung Lin; Thierry Burnouf
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

Review 8.  Convalescent Plasma Therapy for COVID-19: State of the Art.

Authors:  Daniele Focosi; Arthur O Anderson; Julian W Tang; Marco Tuccori
Journal:  Clin Microbiol Rev       Date:  2020-08-12       Impact factor: 26.132

Review 9.  Modern plasma fractionation.

Authors:  Thierry Burnouf
Journal:  Transfus Med Rev       Date:  2007-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.